Covaxin third dose demonstrates long-term safety with no serious adverse events, study, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

Reactogenicity after vaccine and placebo was minimal and comparable,and no serious adverse events were reported, the study indicates., Reactogenicity after vaccine and placebo was minimal and comparable,and no serious adverse events were reported, the study indicates., , Read More

Leave a Reply

Your email address will not be published. Required fields are marked *